2024 | RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19 Deletion Variants | Nishino, Kazumi; JIN-YUAN SHIH ; Nakagawa, Kazuhiko; Reck, Martin; Garon, Edward B; Carlsen, Michelle; Matsui, Tomoko; Visseren-Grul, Carla; Nadal, Ernest | JTO clinical and research reports | | | |
2023 | TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC | Levy, Benjamin P; Felip, Enriqueta; Reck, Martin; CHIH-HSIN YANG ; Cappuzzo, Federico; Yoneshima, Yasuto; Zhou, Caicun; Rawat, Siddhartha; Xie, Jingdong; Basak, Priyanka; Xu, Lu; Sands, Jacob | Future oncology (London, England) | 5 | 1 | |